Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the enhanced suppression of the platelet IIb/IIIa receptor with integrilin therapy [ESPRIT] trial)

Marino Labinaz, Mina Madan, J. Conor O'Shea, Rakhi Kilaru, Wai Chin, Karen Pieper, Darren K McGuire, Jorge F. Saucedo, J. David Talley, Henry Lui, Michael M. Kitt, Robert M. Califf, James E. Tcheng